Otros idiomas Anatara Lifesciences Ltd

Acciones

ANR

AU000000ANR0

Diferido Australian S.E. Otros sitios de cotización 01:59:59 06/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,048 ^AUD	0,00 %		-2,04 %	+118,18 %

01/05	Anatara Lifesciences recauda 1 millón de dólares australianos mediante la colocación de acciones; las acciones caen un 6	MT
09/04	Anatara Lifesciences inicia el reclutamiento para la segunda fase del ensayo sobre el síndrome del intestino irritable	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Anatara Lifesciences Raises AU$1 Million via Shares Placement; Shares Decline 6%	01/05
Anatara Lifesciences Begins Recruitment for Irritable Bowel Syndrome Stage Two Trial	09/04
Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Anatara Lifesciences Raised Nealy AU$960,000 Via Entitlement Offer	08/12
Anatara Lifesciences Limited Webinar on the Company's Stage 1 Irritable Bowel Syndrome	18/10/23
Anatara Lifesciences Limited (ASX:ANR) Webinar on the Company's Stage 1 Irritable Bowel Syndrome	18/10/23
Anatara Lifesciences Ltd Announces Board Changes	01/10/23
Anatara Lifesciences to Proceed to Stage II of IBS Drug Trial	28/09/23
Anatara Lifesciences Finalizes Patients for Irritable Bowel Syndrome Clinical Trial Stage One	31/08/23
Anatara Lifesciences Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	24/08/23
Anatara Lifesciences Receives R&D Tax Rebate; Shares Up 3%	14/08/23
Anatara Lifesciences Ltd Announces Registered Office Change	20/04/23
Anatara Lifesciences Provides Update on the Gastrointestinal Reprogramming(Garp) Trial for IBS	09/03/23
Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	23/02/23
Anatara Lifesciences Ltd Announces board Changes	06/12/22
Anatara Lifesciences Raising Funds for Patient Trial, Future Project Acquisitions	21/10/22
Anatara Lifesciences Receives More than $310,000 R&D Tax Rebate	05/10/22
CSIRO Halts Psychological Functioning Trial for Dietary Supplement	03/10/22
Anatara Lifesciences Limited Provides Updates on 3FDC Clinical Trial	02/10/22
Anatara Lifesciences Limited Reports Earnings Results for the Full Year Ended June 30, 2022	29/08/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Anatara Lifesciences Ltd

Acciones

ANR

AU000000ANR0

Otros idiomas

Filtros